RR Stock Analysis: Richtech Robotics Common | NASDAQ
Specialty Industrial Machinery | NASDAQ, USA | Market Cap: 438m USD | 12M Return: 35% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 19.8M
Rev. Trend: -71.0%
Warnings
Tailwinds
No distinct edge detected
Seasonality
Richtech Robotics Inc. (NASDAQ: RR) is a Las Vegas-based company founded in 2016 (originally as Richtech Creative Displays LLC, renamed in June 2022) that develops, manufactures, and sells robotic automation solutions for the U.S. service industry. Its product portfolio spans commercial service robots - including the Matradee restaurant line and the ADAM and Scorpion dual-arm AI-powered robots for hospitality and retail - as well as industrial offerings such as the Titan autonomous mobile robot (AMR) for deliveries, the DUST-E autonomous cleaning robot, and the Dex industrial humanoid robot aimed at manufacturing, logistics, and material-handling tasks. Beyond hardware, the company provides data generation services for embodied AI training and operates its own Clouffee & Tea robotic restaurant brand, reflecting a vertically integrated model that pairs product sales with operational validation of its own technology. The company reaches customers across food service, retail, industrial manufacturing, automotive, healthcare, and hospitality through digital marketing, sales outreach, industry exhibitions, referrals, online inquiries, and distribution partners. Listed on NASDAQ in November 2023, Richtech sits within the Industrial Machinery & Supplies & Components sub-industry, a small-cap player in the broader service and industrial robotics space, which has been gaining traction as labor shortages and rising operating costs push businesses toward automation.
- Service robot demand from hospitality and retail drives revenue
- Industrial AMR and humanoid Dex segment expands into logistics
- AI data generation services provide new high-margin revenue stream
| Net Income: -20.6m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.04 > 0.02 and ΔFCF/TA 23.06 > 1.0 |
| NWC/Revenue: 6.55k% < 20% (prev 876.2%; Δ 5.67k% < -1%) |
| CFO/TA -0.02 > 3% & CFO -7.05m > Net Income -20.6m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 35.73 > 1.5 & < 3 |
| Outstanding Shares: last quarter (197.7m) vs 12m ago 106.4% < -2% |
| Gross Margin: 55.83% > 18% (prev 73.90%; Δ -18.07% > 0.5%) |
| Asset Turnover: 2.46% > 50% (prev 8.54%; Δ -6.07% > 0%) |
| Interest Coverage Ratio: -319.2 > 6 (EBIT TTM -25.9m / Interest Expense TTM 81.0k) |
| A: 0.93 (Total Current Assets 332.6m - Total Current Liabilities 9.31m) / Total Assets 349.4m |
| B: -0.09 (Retained Earnings -32.1m / Total Assets 349.4m) |
| C: -0.13 (EBIT TTM -25.9m / Avg Total Assets 200.4m) |
| D: 34.86 (Book Value of Equity 339.7m / Total Liabilities 9.74m) |
| Altman-Z'' = 41.50 = AAA |
| DSRI: 0.79 (Receivables 1.89m/2.12m, Revenue 4.93m/4.39m) |
| GMI: 1.32 (GM 73.90% / 55.83%) |
| AQI: 0.15 (AQ_t 0.03 / AQ_t-1 0.20) |
| SGI: 1.12 (Revenue 4.93m / 4.39m) |
| TATA: -0.04 (NI -20.6m - CFO -7.05m) / TA 349.4m) |
| Beneish M = -3.32 (Cap -4..+1) = AA |
As of July 05, 2026, the stock is trading at USD 1.96 with a total of 7,119,300 shares traded. Over the past week, the price has changed by -1.44%, over one month by -28.08%, over three months by -20.81% and over the past year by +34.98%.
Current recommended Stop Loss: 1.70 (which is 13.3% or 1.3 ATR below the current price).
Richtech Robotics Common has received a consensus analysts rating of 4.67. Therefore, it is recommended to buy RR.
- StrongBuy: 2
- Buy: 1
- Hold: 0
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 4 | 104.1% |
P/S = 88.8041
P/B = 1.3626
Revenue TTM = 4.93m USD
EBIT TTM = -25.9m USD
EBITDA TTM = -23.7m USD
Long Term Debt = 326k USD (estimated: total debt 607k - short term 281k)
Short Term Debt = 281k USD (from shortTermDebt, last quarter)
Debt = 607k USD (from shortLongTermDebtTotal, last quarter) (leases 607k already included)
Net Debt = -327.9m USD (calculated: Debt 607k - CCE 328.5m)
Enterprise Value = 110.4m USD (438.2m + Debt 607k - CCE 328.5m)
Interest Coverage Ratio = -319.2 (Ebit TTM -25.9m / Interest Expense TTM 81.0k)
EV/FCF = -8.73x (Enterprise Value 110.4m / FCF TTM -12.6m)
FCF Yield = -11.46% (FCF TTM -12.6m / Enterprise Value 110.4m)
FCF Margin = -256.2% (FCF TTM -12.6m / Revenue TTM 4.93m)
Net Margin = -417.4% (Net Income TTM -20.6m / Revenue TTM 4.93m)
Gross Margin = 55.83% ((Revenue TTM 4.93m - Cost of Revenue TTM 2.18m) / Revenue TTM)
Gross Margin QoQ = 52.31% (prev 39.20%)
Tobins Q-Ratio = 0.32 (Enterprise Value 110.4m / Total Assets 349.4m)
Interest Expense / Debt = 13.34% (Interest Expense 81.0k / Debt 607k)
Taxrate = 21.0% (US federal default 21%)
NOPAT = -20.4m (EBIT -25.9m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 35.73 (Total Current Assets 332.6m / Total Current Liabilities 9.31m)
Debt / Equity = 0.00 (Debt 607k / totalStockholderEquity, last quarter 339.7m)
Debt / EBITDA = 13.84 (negative EBITDA) (Net Debt -327.9m / EBITDA -23.7m)
Debt / FCF = 25.94 (negative FCF - burning cash) (Net Debt -327.9m / FCF TTM -12.6m)
Total Stockholder Equity = 192.9m (last 4 quarters mean from totalStockholderEquity)
RoA = -10.28% (Net Income -20.6m / Total Assets 349.4m)
RoE = -10.68% (Net Income TTM -20.6m / Total Stockholder Equity 192.9m)
RoCE = -13.38% (EBIT -25.9m / Capital Employed (Equity 192.9m + L.T.Debt 326k))
RoIC = -6.01% (negative operating profit) (NOPAT -20.4m / Invested Capital 340.1m)
WACC = 22.83% (E(438.2m)/V(438.9m) * Re(22.85%) + D(607k)/V(438.9m) * Rd(13.34%) * (1-Tc(0.21)))
Discount Rate = 22.85% (= CAPM, Blume Beta Adj.) -> capped to 13.17%
Shares (quarterly) Correlation: 94.39 | Cagr: 63.69%
[DCF] Fair Price = unknown (Cash Flow -12.6m)
EPS Correlation: N/A | EPS CAGR: N/A | SUE: N/A | # QB: 0
Revenue Correlation: -71.02 | Revenue CAGR: -23.03% | SUE: N/A | # QB: 0
EPS current Quarter (2026-03-31): EPS=-0.04 | Chg30d=N/A | Revisions=+0% | Analysts=2
EPS next Quarter (2026-06-30): EPS=-0.04 | Chg30d=N/A | Revisions=-25% | Analysts=2
EPS current Year (2026-09-30): EPS=-0.17 | Chg30d=-65.00% | Revisions=-25% | GrowthEPS=-26.9% | GrowthRev=+70.6%
EPS next Year (2027-09-30): EPS=-0.14 | Chg30d=N/A | Revisions=+0% | GrowthEPS=+15.2% | GrowthRev=+78.3%
[Analyst] Revisions Ratio: -40% (up=0, down=2)